ICON Public Limited Company (NASDAQ:ICLR) is among the 11 Cheap Growth Stocks to Buy Right Now.
On February 23, 2026, Jefferies analyst David Windley upgraded ICON Public Limited Company (NASDAQ:ICLR) to Buy from Hold and lowered the price target to $135 from $175. David Windley said the stock’s current valuation makes ICON “hard to ignore.” David Windley added that while AI could compress labor-intensive businesses, the market may be underestimating the “high regulatory hurdles to rapid tech adoption” and the potential for efficiency gains to be reinvested into research and development.
On February 18, 2026, TD Cowen analyst Charles Rhyee upgraded ICON to Buy from Hold with a price target of $120, down from $183. Charles Rhyee said the selloff tied to the company’s internal accounting investigation appears overdone and that the 33% pullback may overstate the potential earnings impact. TD Cowen estimates that a 2% reduction to revenue forecasts in 2026 and 2027 would translate to a 14% hit to earnings. Charles Rhyee described the risk and reward as “compelling” at current levels despite ongoing investigation risks.
Earlier in February, ICON said it plans to release its fourth quarter and full year 2025 results on or before April 30. The company also disclosed an internal investigation launched by the Audit Committee in October 2025 into certain accounting practices and controls, focusing primarily on revenue recognition from fiscal years 2023 through 2025. Preliminary findings indicate revenue for 2023 and 2024 may have been overstated by less than two percent for each year. The company is reviewing internal controls over financial reporting and expects to report one or more material weaknesses. Due to the ongoing investigation and delays in reporting processes, ICON withdrew its previously issued 2025 full-year financial guidance.
ICON Public Limited Company (NASDAQ:ICLR) provides outsourced development and commercialization services to pharmaceutical, biotechnology, and medical device companies globally.
While we acknowledge the potential of ICLR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ICLR and that has a 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 12 Best Tech Stocks that Beat Earnings Estimates and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026
Disclosure: None. Follow Insider Monkey on Google News.
